Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

2.54
-0.0200-0.78%
Post-market: 2.540.00000.00%18:56 EDT
Volume:79.41K
Turnover:202.58K
Market Cap:21.27M
PE:-0.58
High:2.74
Open:2.61
Low:2.51
Close:2.56
52wk High:22.20
52wk Low:2.02
Shares:8.38M
Float Shares:6.31M
Volume Ratio:1.99
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4145
EPS(LYR):-9.4201
ROE:-424.97%
ROA:-84.22%
PB:5.28
PE(LYR):-0.27

Loading ...

Femasys - Announces 1-for-20 Reverse Stock Split Effective June 5, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 04

Femasys to enact 1-for-20 reverse stock split June 5

Reuters
·
Jun 04

Femasys updates corporate presentation on women’s health portfolio

TIPRANKS
·
May 14

Femasys Expands Fertility Care Portfolio in Europe With Ce Mark Approval for Femhsg™ Catheter

THOMSON REUTERS
·
May 13

Femasys wins CE Mark approval for FemHSG catheter in Europe

Reuters
·
May 13

Lake Street Remains a Buy on Femasys (FEMY)

TIPRANKS
·
May 12

Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns

TIPRANKS
·
May 10

Femasys Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 09

Femasys Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Femasys Q1 sales rise on FemBloc demand

Reuters
·
May 09

Femasys Inc. Q1 EPS USD 0

THOMSON REUTERS
·
May 09

Femasys swings to Q1 profit of 846,100; sales rise 24.5% to 424,889

Reuters
·
May 09

Femasys Q1 Sales $424.889K Miss $767.000K Estimate

Benzinga Earnings
·
May 09

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

THOMSON REUTERS
·
May 09

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

GlobeNewswire
·
May 05

Femasys Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 05

Femasys Shareholders Approve Reverse Split and Financing Plans

TIPRANKS
·
Apr 30

Femasys shareholders approved reverse stock split amendment at special meeting

Reuters
·
Apr 30

Analysts Are Bullish on These Healthcare Stocks: Femasys (FEMY), ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Apr 28

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

GlobeNewswire
·
Apr 22